EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antifungal Activity, Cytocompatibility, and Wound Healing Potential of Novel Mucoadhesive Formulations for Oral Drug Delivery

Carolina Yoshi Campos Sugio iD, Victor Martin iD, Lídia Maria Diogo Gonçalves iD, Priscileila Coleto Ferrari iD, Vanessa Migliorini Urban iD, Karin Hermana Neppelenbroek iD, Maria Helena Fernandes iD

Journal of Biomedical Materials Research Part A · 2025

DOI: 10.1002/jbm.a.37990 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Carolina Yoshi Campos Sugio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Prosthodontics and Periodontics, Bauru School of Dentistry, University of São Paulo (USP), Bauru, São Paulo, Brazil. Hauptthemen laut MEDLINE: Wound Healing, Antifungal Agents, Candida albicans, Drug Delivery Systems. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação para a Ciência e a Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional treatments for oral candidiasis often fail due to the complexities of the oral environment and the increasing antifungal drug resistance. Therefore, there is a growing demand for new therapies that optimize drug bioavailability, allowing for lower therapeutic doses while enhancing cytocompatibility, maintaining antifungal, anti‐inflammatory, and wound healing efficacy. This study investigated the antifungal activity, cytocompatibility, wound healing potential, and mucosal adhesion of novel mucoadhesive formulations containing nystatin (NYS) or chlorhexidine (CHX) complexed with β‐cyclodextrin (βCD), compared with the drug‐free formulation (GEL) and the standard treatment with 2% miconazole gel (DK—Daktarin). Efficacy against Candida albicans was evaluated by measuring the metabolic activity, whereas cytocompatibility with human gingival fibroblasts (HGFs) was analyzed for viability, morphology, lactate dehydrogenase (LDH) release, and apoptosis. Additionally, wound healing potential was investigated by assessing cell migration efficacy, anti‐inflammatory activity, and reactive oxygen species (ROS) scavenging activity. Mucoadhesion was evaluated using mucin discs and a texture analyzer. Mucoadhesive gels containing βCD‐complexed NYS or CHX exhibited significantly higher antifungal activity when compared to the GEL and DK groups ( p < 0.05). Compared to fibroblast control cultures, those exposed to drug‐complexed gels exhibited similar viability ( p > 0.05) and morphological parameters, lower LDH release ( p < 0.05), and similar apoptosis rates ( p > 0.05). Additionally, exposure to the βCD‐modified gels was associated with complete wound closure ( p > 0.05), significant anti‐inflammatory effect, with downregulation of pro‐inflammatory gene expression ( p < 0.05), and higher ROS scavenging activity ( p < 0.05). The developed formulations showed no difference in mucoadhesiveness ( p > 0.05), which was superior to that of DK ( p < 0.05). Therefore, the proposed drug‐complexed mucoadhesives are promising therapeutic options for oral candidiasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingAntifungal AgentsCandida albicansDrug Delivery SystemsHumansFibroblastsAdministration, OralGingivaNystatinChlorhexidineReactive Oxygen SpeciesCell SurvivalCell MovementAdhesivenessMiconazole

Stichwörter der Autor:innen

Candida albicanschlorhexidinecyclodextrinsdrug delivery systemsnystatinoral candidiasis

Substanzen

Antifungal AgentsNystatinChlorhexidineReactive Oxygen SpeciesMiconazole

Autor:innen und Institutionen

  • Department of Prosthodontics and Periodontics, Bauru School of Dentistry, University of São Paulo (USP), Bauru, São Paulo, Brazil.
  • Department of Removable Prosthodontics and Dental Materials, Dental School, Federal University of Uberlândia (UFU), Uberlândia, Minas Gerais, Brazil.
  • BoneLab, Faculdade de Medicina Dentária, Universidade do Porto, Porto, Portugal.
  • LAQV, REQUIMTE, Faculdade de Medicina Dentária, Universidade do Porto, Porto, Portugal.
  • Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Lisbon, Portugal.
  • Department of Pharmaceutical Sciences, State University of Ponta Grossa (UEPG), Ponta Grossa, Paraná, Brazil.

ORCID-Profile: Carolina Yoshi Campos Sugio, Victor Martin, Lídia Maria Diogo Gonçalves, Priscileila Coleto Ferrari, Vanessa Migliorini Urban, Karin Hermana Neppelenbroek, Maria Helena Fernandes

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Fundação para a Ciência e a Tecnologia
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Sugio, C. Y. C., Martin, V., Gonçalves, L. M. D., Ferrari, P. C., Urban, V. M., Neppelenbroek, K. H., & Fernandes, M. H. (2025). Antifungal Activity, Cytocompatibility, and Wound Healing Potential of Novel Mucoadhesive Formulations for Oral Drug Delivery. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37990

Vancouver

Sugio CYC, Martin V, Gonçalves LMD, Ferrari PC, Urban VM, Neppelenbroek KH, et al. Antifungal Activity, Cytocompatibility, and Wound Healing Potential of Novel Mucoadhesive Formulations for Oral Drug Delivery. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.37990

BibTeX
@article{Sugio2025,
  author = {Sugio, Carolina Yoshi Campos and Martin, Victor and Gonçalves, Lídia Maria Diogo and Ferrari, Priscileila Coleto and Urban, Vanessa Migliorini and Neppelenbroek, Karin Hermana and Fernandes, Maria Helena},
  title = {Antifungal Activity, Cytocompatibility, and Wound Healing Potential of Novel Mucoadhesive Formulations for Oral Drug Delivery},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2025},
  doi = {10.1002/jbm.a.37990}
}
Kostenlos starten →